Rating Change
Jones Trading analysts upgraded Capricor Therapeutics, Inc. (NASDAQ:CAPR) from Hold to Buy on November 11, 2026.
upgradeNASDAQ:CAPR
Capricor Therapeutics, Inc. (CAPR) Upgraded to Buy at Jones Trading
Jones Trading analysts upgraded Capricor Therapeutics, Inc. (NASDAQ:CAPR) from Hold to Buy on November 11, 2026.
At publication ·
What changed
Capricor Therapeutics, Inc. (NASDAQ:CAPR) · upgrade
- Firm
- Jones Trading
- Rating
- Hold to Buy
- Price at event
- $11.22
- Market capitalization
- $1.2B
At a glance
Key takeaways
- Jones Trading upgraded Capricor Therapeutics (CAPR) from Hold to Buy on November 11, 2026.
- The stock trades at $11.22 with a $1.2B market cap and has gained 89.2% over the past 52 weeks.
- Among the 10 most recent analyst ratings, 6 are Buy and 4 are Hold, with no Sell ratings.
- Analyst upgrades can act as catalysts for near-term price movement, though ratings have mixed predictive power on their own.
Market Context
Capricor Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $11.22 with a market capitalization of $1.2B. The stock has gained 89.2% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Jones Trading's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Capricor Therapeutics, Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 11, 2026 | Jones Trading | Buy | N/A |
| Sep 14, 2026 | B. Riley Securities | Buy | N/A |
| Sep 01, 2026 | Piper Sandler | Overweight | N/A |
| Aug 14, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Jul 31, 2026 | Jones Trading | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View CAPR Stock Page
Frequently Asked Questions
What does the Buy rating mean for CAPR?
A rating of Buy from Jones Trading reflects the analyst's outlook on Capricor Therapeutics, Inc. (NASDAQ:CAPR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CAPR forecast page.
Loading related coverage…
